MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
12.58
+0.17
+1.37%
After Hours: 12.57 -0.01 -0.08% 18:36 02/06 EST
OPEN
12.82
PREV CLOSE
12.41
HIGH
12.94
LOW
12.20
VOLUME
950.61K
TURNOVER
--
52 WEEK HIGH
18.31
52 WEEK LOW
2.210
MARKET CAP
980.21M
P/E (TTM)
-3.2997
1D
5D
1M
3M
1Y
5Y
1D
Institutional investors in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) see US$88m decrease in market cap last week, although long-term gains have benefitted them.
Simply Wall St · 2d ago
Phathom Pharmaceuticals to Present at Guggenheim Emerging Outlook Biotech Summit
Reuters · 2d ago
Weekly Report: what happened at PHAT last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at PHAT last week (0119-0123)?
Weekly Report · 01/26 09:48
Analysts Offer Insights on Healthcare Companies: Oscar Health (OSCR) and Phathom Pharmaceuticals (PHAT)
TipRanks · 01/22 13:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and Phathom Pharmaceuticals (PHAT)
TipRanks · 01/22 13:21
Weekly Report: what happened at PHAT last week (0112-0116)?
Weekly Report · 01/19 09:52
Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Phathom Pharmaceuticals (PHAT)
TipRanks · 01/15 11:50
More
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s product candidates include VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker, or potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.